Related references
Note: Only part of the references are listed.Pharmacogenomics Clinical Annotation Tool (PharmCAT)
Katrin Sangkuhl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
PharmVar GeneFocus: CYP2D6
Charity Nofziger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant
Jai N. Patel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
Mary V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
PharmVar and the Landscape of Pharmacogenetic Resources
Andrea Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Kelly E. Caudle et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Drug-drug-gene interactions and adverse drug reactions
Mustafa Adnan Malki et al.
PHARMACOGENOMICS JOURNAL (2020)
Long-Distance Phasing of a Tentative Enhancer Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions
Erin C. Boone et al.
FRONTIERS IN PHARMACOLOGY (2020)
Stargazer: a software tool for calling star alleles from nextgeneration sequencing data using CYP2D6 as a model
Seung-been Lee et al.
GENETICS IN MEDICINE (2019)
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
Larisa H. Cavallari et al.
GENETICS IN MEDICINE (2019)
The Missing Diversity in Human Genetic Studies (vol 177, pg 26, 2019)
Giorgio Sirugo et al.
CELL (2019)
Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection
Chad A. Bousman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Modulation of CYP450 Activities in Patients With Type 2 Diabetes
Sophie Gravel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles
Mariana R. Botton et al.
HUMAN MUTATION (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research
Rachel Huddart et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The Evolution of PharmVar
Andrea Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
Frederick Zhang et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2019)
Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel
Mirjana Novkovic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics
Maria Santos et al.
GENETICS IN MEDICINE (2018)
Cytochrome P450 and flavin-containing monooxygenase families: age-dependent differences in expression and functional activity
Nicole R. Zane et al.
PEDIATRIC RESEARCH (2018)
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)
Thomas O. Bergmeijer et al.
AMERICAN HEART JOURNAL (2018)
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Larisa H. Cavallari et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2018)
Recommendations for Clinical CYP2C19 Genotyping Allele Selection A Report of the Association for Molecular Pathology
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes
Ibrahim Numanagic et al.
NATURE COMMUNICATIONS (2018)
The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
Ren-ai Xu et al.
INFECTION AND DRUG RESISTANCE (2018)
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
Andrea Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
P450 Pharmacogenetics in Indigenous North American Populations
Lindsay M. Henderson et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24
Pui Shen Lau et al.
BIOCHEMICAL GENETICS (2017)
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
Kelly E. Caudle et al.
GENETICS IN MEDICINE (2017)
Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting
Chad A. Bousman et al.
PHARMACOGENETICS AND GENOMICS (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts
P. J. Caraballo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy
B. Moriyama et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting
L. H. Cavallari et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Integrating pharmacogenomics into electronic health records with clinical decision support
J. Kevin Hicks et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes A GeT-RM Collaborative Project
Victoria M. Pratt et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
Carolina Céspedes-Garro et al.
REVISTA DE BIOLOGIA TROPICAL (2016)
Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences
Greyson P. Twist et al.
NPJ GENOMIC MEDICINE (2016)
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver
K. S. Burgess et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Zhi-Wei Zhou et al.
DRUGS (2015)
In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population
Da-Peng Dai et al.
XENOBIOTICA (2015)
Genenames.org: the HGNC resources in 2015
Kristian A. Gray et al.
NUCLEIC ACIDS RESEARCH (2015)
Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation
M. Takahashi et al.
PHARMACOGENOMICS JOURNAL (2015)
A Rapid Molecular Approach for Chromosomal Phasing
John F. Regan et al.
PLOS ONE (2015)
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Kelly E. Caudle et al.
CURRENT DRUG METABOLISM (2014)
Clinical consequences of polypharmacy in elderly
Robert L. Maher et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Distribution of CYP2D6 and CYP2C19 Polymorphisms Associated with Poor Metabolizer Phenotype in Five Amerindian Groups and Western Mestizos from Mexico
Joel Salazar-Flores et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19
Stuart A. Scott et al.
PHARMACOGENETICS AND GENOMICS (2012)
Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations
Ángela Roco et al.
Frontiers in Genetics (2012)
Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
Huijuan Wang et al.
DRUG METABOLISM AND DISPOSITION (2011)
In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3
Souzan B. Yanni et al.
DRUG METABOLISM AND DISPOSITION (2010)
Characterization of the genetic profile of CYP2C19 in two South African populations
Britt I. Drogemoeller et al.
PHARMACOGENOMICS (2010)
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
Dominick J. Angiolillo et al.
CIRCULATION (2007)
A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
SC Sim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects
K Laine et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Human cytochrome P450 (CYP) genes:: recommendations for the nomenclature of alleles
M Ingelman-Sundberg et al.
PHARMACOGENETICS (2000)
Share Paper
